v3.25.4
INVESTMENTS - Recognition and Measurement of Impairment Losses (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]      
Impairment losses recognized in earnings for debt securities that the Company intends to sell, would more-likely-than-not be required to sell or will be subject to an issuer call deemed probable of exercise $ 184 $ 323 $ 188
Total impairment losses recognized in earnings $ 184 $ 323 $ 188